Infertility Treatment Devices And Equipment Market Scope And Analysis

  • Report Code : TIPRE00007059
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Infertility Treatment Devices and Equipment Market Analysis, Trends, and Scope 2023 to 2031

Buy Now


Infertility Treatment Devices and Equipment Market Report Scope

Report Attribute Details
Market size in 2022 US$ 1.39 Billion
Market Size by 2031 US$ 3.23 Billion
Global CAGR (2023 - 2031) 9.83%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Product Type
  • Sperm Separation Devices
  • Ovum Aspiration Pumps Sperm Analyzer Systems
  • Micromanipulator Systems
  • Incubators
By Procedure
  • Fertility Surgery
  • Assisted Reproductive Technology
  • Artificial Insemination
By Procedure
  • Fertility Surgery
  • Assisted Reproductive Technology
  • Artificial Insemination
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher Scientific
  • Cook Group
  • Vitrolife
  • IVFtech APS
  • Hamilton Thorne Ltd
  • Esco Micro Pte Ltd
  • Genea Biomedx Ltd
  • FUJIFILM Irvine Scientific
  • Eppendorf AG
  • Baker Company INC
  • Infertility Treatment Devices and Equipment Market News and Recent Developments

    The infertility treatment devices and equipment market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for infertility treatment devices and equipment:

    • Trajan Scientific and Medical supplied CE-IVD-registered Mitra devices to Fertilly, a German start-up. Fertilly launched Europe's first At-Home Fertility Test Kits using dried blood microsampling with VAMS technology. The Mitra microsampling devices allow for quick and easy collection of blood samples through finger sticks, which can then be mailed to a lab for analysis as dried blood. (Source: Trajan Scientific Australia Pty Ltd, Press Release, 2023)
    • Merck Specialties Pvt ltd, the healthcare business of Merck in India, launched the Pergoveris Pen for advanced infertility treatment in India. This launch emphasizes the company’s motive of fulfilling unmet medical needs by providing an improved, convenient, and ready-to-use combination treatment option for women with severe follicle-stimulating hormone (FSH) and luteinizing hormone (LH) deficiency. (Source: Merck Specialties Pvt ltd, Press Release, 2021)

    Infertility Treatment Devices and Equipment Market Report Coverage and Deliverables

    The “Infertility Treatment Devices and Equipment Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles